Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Implications of the Inflation Reduction Act for cancer medicine development
    30 September 2024

    Implications of the Inflation Reduction Act for cancer medicine development

    The Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program (MDPNP) directs the Secretary of Health and Human Services (HHS) to set a maximum price for certain drugs in Medicare. The MDPNP is expected to reduce the pharmaceutical company revenues in Medicare from a selecte...

    Yourgene Health Logo
    17 October 2024

    Yourgene Health Cystic Fibrosis Base assay receives IVDR accreditation

    Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene® Cystic Fibrosis Base assay. The Yourge...

    Cellular Origins and Fresenius Kabi
    16 October 2024

    Cellular Origins, Fresenius Kabi sign development agreement for scalable automation of cell and gene therapy manufacturing

    Companies to develop integration strategies for Fresenius Kabi’s portfolio of Cell Therapy Technologies within Cellular Origins’ Constellation automation platform Initial research to focus on integration of the Cue® Cell Processing System for automated small volume processing CAMBR...

    Dr Michael Chen Standing With eProtein Discovery Holding eProtein Discovery Cartridge
    16 October 2024

    Nuclera closes $75 million USD financing

    Series C round led by Elevage Medical Technologies. Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally. ...

    Sapio Sciences
    16 October 2024

    Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities

    Enhancements support ADA and NAb testing workflows, boosting lab efficiency and regulatory compliance for drug development Baltimore, MD – Sapio Sciences, the science-aware™ lab informatics platform, announces the addition of new immunogenicity bioanalysis features to its indus...

    Daniel Ives, CEO, Shift Bioscience
    16 October 2024

    Shift Bioscience raises $16M to advance cell simulation AI platform

    Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner Seed funding will accelerate development of Shift Bioscience’s platform for identification of safe rejuvenation genes, a fundamental step forward in the development of t...

    Menopause matters_copywrite Canva
    16 October 2024

    Menopause matters – how to support staff going through menopause

    Menopause will affect almost half the workforce in the UK. But this natural stage of life is still taboo for lots of employers. This Menopause Awareness Month, we’re looking at how to create a supportive environment for menopausal employees. We’ll also see how doing that can improve and...

    Plaster
    15 October 2024

    Benefits of a Nitrosamine Selective Detector

    Nitrosamines, such as N-Nitrosodimethylamine (NDMA), are carcinogenic compounds that can form during the drug manufacturing process and storage under certain conditions. These contaminants pose significant health risks, and their presence in medications like Ranitidine has alr...

    make up
    15 October 2024

    Ensuring cosmetic safety: the vital role of ATNC analysis

    Cosmetics aren't just about enhancing beauty; they're about trust and safety. In the intricate dance of beauty and science, the discovery of nitrosamines within our cherished products has cast a shadow, highlighting the need for safety measures. The ATNC Analysis, a beacon of precision ...

    Awards
    16 October 2024

    Guardtech Group bag third win in two months with West Suffolk Innovation of the Year Award

    Haverhill-based cleanroom construction specialists scoop Bury Free Press Awards win for Innovation with portable container business Cleancube Mobile Cleanrooms ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 114
    • Page 115
    • Current page 116
    • Page 117
    • Page 118
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS